Tomás Suárez‐Zarracina

Author

Hospital Universitario Central de Asturias

Also Known As

María Eugenia Rivas Carmenado, S Tomás, T Suarez‐Zarracina, T Suárez-Zarracina, T. Suarez-Zarracina, T. Suárez‐Zarracina, Tomas Suarez-Zarracina, Tomás Suarez-Zarracina, Tomás Suárez-Zarracina, Tomás Suárez‐Zarracina

Publications

297

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Central de Asturias Hospital de Galdakao Instituto Ramón y Cajal de Investigación Sanitaria Instituto de Salud Carlos III Hospital Universitario Ramón y Cajal

About

Tomás Suárez‐Zarracina is an author at Hospital Universitario Central de Asturias specializing in medicine, immunology, and hiv.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	128
2	Immunology	2	2	97
3	Epidemiology	1	1	68
4	Neurology	1	1	31
5	Pathology	1	1	29

Tomás Suárez‐Zarracina

Publications

280

Citations

H-Index

Page 1

	Year	Citations
Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study Sergio Serrano‐Villar, Javier Martínez‐Sanz, Raquel Ron, The Lancet HIV Primary ImmunodeficiencyTreatment And PreventionHuman RetrovirusImmunologyFirst-line Antiretroviral Therapy	2020	68
Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events Javier Martínez‐Sanz, Jorge Díaz-Álvarez, Marta Rosas Cancio-Suárez, EBioMedicine	2023	32
Meropenem monotherapy is as effective as and safer than imipenem to treat brain abscesses G. Martin-Canal, Álvaro Saavedra, José María Asensi, International Journal of Antimicrobial Agents Brain InjuryNeurologyBrain AbscessesMedicineMeropenem Monotherapy	2010	31
The effect of gender and genetic polymorphisms on matrix metalloprotease (MMP) and tissue inhibitor (TIMP) plasma levels in different infectious and non-infectious conditions J. Collazos, Víctor Asensi, A. Hugo Montes, Clinical & Experimental Immunology ImmunodeficienciesGenetic EpidemiologyImmunologyPathologyImmune Regulation	2015	29
Didanosine (ddI) associates with increased liver fibrosis in adult HIV–HCV coinfected patients Tomás Suárez‐Zarracina, Eulalia Valle-Garay, J. Collazos, Journal of Viral Hepatitis	2012	27
Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice Inés Suárez‐García, Belén Alejos, Víctoria Hernando, Journal of Antimicrobial Chemotherapy	2023	26
High-Level Carbapenem Resistance among OXA-48-Producing Klebsiellapneumoniae with Functional OmpK36 Alterations: Maintenance of Ceftazidime/Avibactam Susceptibility Pilar Lumbreras-Iglesias, M. Rosario Rodicio, Pablo Valledor, Antibiotics	2021	18
Factors Associated with Liver Fibrosis in Intravenous Drug Users Coinfected with HIV and HCV J. A. Cartón, Julio Collazos, Belén de la Fuente, Antiviral Therapy	2011	16
Sex differences in hospitalized adult patients with cellulitis: A prospective, multicenter study Julio Collazos, Belén de la Fuente, Javier de la Fuente, International Journal of Infectious Diseases	2021	12
The MMP1 (−16071G/2G) single nucleotide polymorphism associates with the HAART-related lipodystrophic syndrome A. Hugo Montes, Eulalia Valle-Garay, Tomás Suárez‐Zarracina, AIDS	2010	11

Page 1